Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02838108 · ClinicalTrials.gov registry record
The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 452
- Enrollment target
NCT02838108 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 452 participants.
The verdict
NCT02838108 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 452 participants
- Enrollment target
Study Summary
This is an observational study examining outcomes and treatment patterns in a community-based cohort of subjects with Chronic obstructive pulmonary disease (COPD) who are based in the Kannapolis, NC area.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02838108
The ClinicalTrials.gov registry entry for NCT02838108 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 452 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02838108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02838108 about?
NCT02838108 is a clinical study titled "The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort". This is an observational study examining outcomes and treatment patterns in a community-based cohort of subjects with Chronic obstructive pulmonary disease (COPD) who are based in the Kannapolis, NC area.
What is the current status of trial NCT02838108?
This trial is currently terminated. The enrollment target is 452 participants. The study started on 2016-10. Estimated completion is 2018-04-19.
Who is sponsoring clinical trial NCT02838108?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.